RESQ Pharmaceutical Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $255M

RESQ Pharmaceutical General Information

Description

Developer of novel therapies designed for the outpatient treatment of edema and congestion associated with heart failure, liver, and kidney disease. The company aims to provide outpatient therapeutic options for patients suffering from fluid overload, enabling healthcare professionals to improve patient outcomes and reduce costs.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 3535 Executive Terminal Drive
  • Suite 110
  • Henderson, NV 89052
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 3535 Executive Terminal Drive
  • Suite 110
  • Henderson, NV 89052
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RESQ Pharmaceutical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 02-Apr-2026 $255M Completed Generating Revenue
2. Early Stage VC (Series A) 29-Jun-2021 Completed Generating Revenue
1. Seed Round 23-Apr-2020 $2.47M $2.47M Completed Pre-Clinical Trials
To view RESQ Pharmaceutical’s complete valuation and funding history, request access »

RESQ Pharmaceutical Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cultivation Capital Venture Capital Minority
Triton Funds Venture Capital Minority
To view RESQ Pharmaceutical’s complete investors history, request access »

RESQ Pharmaceutical FAQs

  • When was RESQ Pharmaceutical founded?

    RESQ Pharmaceutical was founded in 2018.

  • Where is RESQ Pharmaceutical headquartered?

    RESQ Pharmaceutical is headquartered in Henderson, NV.

  • What industry is RESQ Pharmaceutical in?

    RESQ Pharmaceutical’s primary industry is Drug Discovery.

  • Is RESQ Pharmaceutical a private or public company?

    RESQ Pharmaceutical is a Private company.

  • What is the current valuation of RESQ Pharmaceutical?

    The current valuation of RESQ Pharmaceutical is .

  • What is RESQ Pharmaceutical’s current revenue?

    The current revenue for RESQ Pharmaceutical is .

  • How much funding has RESQ Pharmaceutical raised over time?

    RESQ Pharmaceutical has raised $11.4M.

  • Who are RESQ Pharmaceutical’s investors?

    Cultivation Capital and Triton Funds have invested in RESQ Pharmaceutical.

  • When was RESQ Pharmaceutical acquired?

    RESQ Pharmaceutical was acquired on 02-Apr-2026.

  • Who acquired RESQ Pharmaceutical?

    RESQ Pharmaceutical was acquired by Esperion Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process